Federal award
WELLS PHARMA OF HOUSTON LLC
W81K0022P0048
Contract
Obligated and Ceiling
- Obligated (net)
- $408,898.69
- Ceiling (potential value, not spending)
- $639,602.69
- Current value
- $639,602.69
- Gross positive obligations
- $787,623.46
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- WELLS PHARMA OF HOUSTON LLC · KZYSEB9YNPR4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- WELLS PHARMA OF HOUSTON LLC · KZYSEB9YNPR4
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81K0022P0048
- Award type code
- B
- Actions
- 13 · Jan 21, 2022 to Mar 27, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 27, 2025 | FY2025 | P00012 | F | −$268,010.35 | — |
| Nov 18, 2024 | FY2025 | P00011 | C | $283,391.88 | — |
| Sep 5, 2024 | FY2024 | P00010 | C | −$110,689.56 | — |
| Jun 24, 2024 | FY2024 | P00009 | C | −$11.20 | — |
| Jun 18, 2024 | FY2024 | P00008 | G | $0.00 | — |
| Dec 5, 2023 | FY2024 | P00007 | C | −$13.66 | — |
| Oct 26, 2023 | FY2024 | P00006 | C | $261,992.38 | — |
| Jul 18, 2023 | FY2023 | P00005 | G | $0.00 | — |
| Mar 31, 2023 | FY2023 | P00004 | M | $0.00 | — |
| Dec 6, 2022 | FY2023 | P00003 | C | $242,239.20 | — |
| Sep 21, 2022 | FY2022 | P00002 | M | $0.00 | — |
| May 4, 2022 | FY2022 | P00001 | G | $0.00 | — |
| Jan 21, 2022 | FY2022 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.